"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...

Weight loss could help improve obstructive sleep apnea in patients with type 2 diabetes mellitus and a BMI ≥25 kg/m 2, say researchers of the Sleep AHEAD (Action for Health in Diabetes ...

Dec. 21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleep apnea.

Several factors affect weight loss, including diet, physical activity, metabolism, psychological factors, stress levels and sleep. Getting enough quality sleep is not only crucial for your overall ...

such challenges can make things even harder to achieve their weight-loss goals. Google searches for ‘tips for better sleep’ have skyrocketed 533 per cent ahead of World Sleep Day on Friday ...